Over the last 50 years, the bioprocessing industry has witnessed tremendous change, overcoming many challenges to increase efficiency and productivity throughout the development and manufacturing process. These efforts have been particularly focused to elicit major advancements for cell lines, culture media, and downstream processes used to produce therapeutics.
MarketsandMarkets is extremely delighted to announce its “ MarketsandMarkets Next-Gen Bioprocessing Virtual Conference” scheduled to be held on 6th- 7th October 2022. The conference is designed for having interactive discussions in cell culture, scale-up, continuous biomanufacturing, recovery, purification, process and product characterization, formulation, case studies in analytics and stability. The conference also includes interactive breakout sessions, solutions and services supporting the rapidly growing bioprocessing industry. The event will witness the participation of decision makers from the pharmaceutical industry who are shaping the future of the bioprocessing industry.
Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast
Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast
Scientific Founder and Chief Scientific Officer, Leucid Bio
Associate Director, National Institute for Cellular Biotechnology
Postdoctoral Researcher, The National Institute for Bioprocessing Research and Training
Post-Doctoral Research Fellow, University College London
Senior Development Director, CMC, Evox Therapeutics Ltd
Associate Technical Director, Apheresis | Global MSAT Cell Therapy Development and Operations, Bristol Myers Squibb
.png)
Professor, Tel Aviv University
Head R&D division, Immuneel Therapeutics
CEO and Co-Founder, Protein Capture Science
